Biotechnology in Turkey

My recent presentation at the “Biotechnology for Turkey” conference has been posted online. My central thesis was that the challenges faced by Turkey (and most any other location) are shared by many states within the United States. I’ve heard too many people opine for the seemingly easy start-up environment in the United States. The reality [...]

FDA Enforcement Trends: 2007-2008

Guest content from John Avellanet, managing director of Cerulean Associates:
The US Food and Drug Administration (FDA) intends to increase regulatory enforcement, extending the recent trend of laboratory and clinical site inspections to unapproved drugs and reformulations. How can you avoid compliance trouble?
At the Food and Drug Law Institute’s 5th Annual Enforcement and Litigation conference, [...]

Drug Patent Expirations in December 2007

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in December 2007*Drugs may be
covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

DOVONEX
Leo Pharm
calcipotriene
4,866,048
DEC 29,2007

FASLODEX
Astrazeneca
fulvestrant
4,659,516
DEC 11,2007

KYTRIL
Roche
granisetron hydrochloride
4,886,808
DEC 20,2007

KYTRIL
Roche
granisetron hydrochloride
4,886,808
DEC 29,2007

MERIDIA
Abbott
sibutramine hydrochloride
4,746,680
DEC 11,2007

REQUIP
Glaxosmithkline
ropinirole hydrochloride
4,452,808
DEC 07,2007

TACLONEX
Leo Pharm Prods
betamethasone dipropionate; calcipotriene hydrate
4,866,048
DEC 29,2007

ZINECARD
Pharmacia And Upjohn
dexrazoxane hydrochloride
4,963,551
DEC 21,2007

ZYRTEC
Pfizer
cetirizine hydrochloride
4,525,358
DEC 25,2007

ZYRTEC-D 12 HOUR
Pfizer
cetirizine hydrochloride; pseudoephedrine hydrochloride
4,525,358
DEC 25,2007

Courtesy of DrugPatentWatch.com

Venture Capital Returns

At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so I said that VCs generally expect that 1/3 of their investments will see great returns, 1/3 will see modest or no returns, and 1/3 will not be profitable.
VC Fred Wilson as Union Square Ventures recently [...]

Call for Papers: Biotechnology Marketing

Journal of Commercial Biotechnology - Special Issue on Product Innovation Management and Marketing
Focus of the Special Issue
Biotechnology companies are product innovation firms, yet they face a collection of challenges which make it inappropriate to simply apply existing innovation management thinking. For instance, at present relatively few biotechnology firms generate earned income from sales. They [...]

Career Development in Biotechnology

I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University of Toronto. More details are available at the MBiotech website.